☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Pericarditis
Kiniksa's Arcalyst (rilonacept) Receives the US FDA's Approval for the Treatment of Pericarditis
March 19, 2021
Kiniksa's Rilonacept Receives the US FDA's Orphan Drug Designation to Treat Pericarditis
July 17, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.